<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-AMB3OTYS/cbaadb04-e202-4693-a6c4-950ecfa3e09e/HTML"><dcterms:extent>11 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-AMB3OTYS/2f384bcf-7f48-4363-98ce-73cc62dc756f/PDF"><dcterms:extent>322 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-AMB3OTYS/ee938a62-e64b-41ae-a614-a24861fc4c48/TEXT"><dcterms:extent>10 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-AMB3OTYS"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:SPR-WQVGMCSC" /><dcterms:issued>2004</dcterms:issued><dc:creator>Reich, Adam</dc:creator><dc:creator>Szepietowski, Jacek C.</dc:creator><dc:creator>Wasik, Feliks</dc:creator><dc:format xml:lang="sl">številka:1</dc:format><dc:format xml:lang="sl">letnik:13</dc:format><dc:format xml:lang="sl">str. 20-24</dc:format><dc:identifier>ISSN:1318-4458</dc:identifier><dc:identifier>COBISSID:17674201</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-AMB3OTYS</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Slovene Welding Society</dc:publisher><dcterms:isPartOf xml:lang="sl">Acta dermatovenerologica Alpina, Pannonica et Adriatica</dcterms:isPartOf><dc:subject xml:lang="sl">Antigeni, CD20</dc:subject><dc:subject xml:lang="sl">Antigeni, CD45</dc:subject><dc:subject xml:lang="en">Antigens, Cd20</dc:subject><dc:subject xml:lang="en">Antigens, Cd45</dc:subject><dc:subject xml:lang="sl">dermatologija</dc:subject><dc:subject xml:lang="en">Diagnosis</dc:subject><dc:subject xml:lang="en">Drug Therapy</dc:subject><dc:subject xml:lang="sl">Eritem</dc:subject><dc:subject xml:lang="en">Erythema</dc:subject><dc:subject xml:lang="en">Immunohistochemistry</dc:subject><dc:subject xml:lang="sl">Imunohistokemija</dc:subject><dc:subject xml:lang="sl">Kožne bolezni</dc:subject><dc:subject xml:lang="sl">Limfociti T</dc:subject><dc:subject xml:lang="en">Middle Age</dc:subject><dc:subject xml:lang="en">Pathology</dc:subject><dc:subject xml:lang="en">Pseudolymphoma</dc:subject><dc:subject xml:lang="sl">Psevdolimfom</dc:subject><dc:subject xml:lang="en">Skin Diseases</dc:subject><dc:subject xml:lang="sl">Srednja leta</dc:subject><dc:subject xml:lang="en">T-Lymphocytes</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Palpable migratory arciform erythema - does this entity really exist?|</dc:title><dc:description xml:lang="sl">Palpable migratory arciform erythema has rarely been reported in medical literature. A 59-year old female patient was referred to our department because of slightly itchy, erythematous lesions on the back, which had been present for the previous 4 years. Previously she had been treated with topicalcorticosteroids without any improvement. Within the 4-year period the lesions had shown a partly spontaneous resolution with the formation of new arciform or semiannular lesions. On admission she presented with 2 elevated and firmly palpable erythematous patches on the back. The lesions had sharp and distinct margins, about 4 cm in diameter, and an annular shape with a tendency towards central clearing. Histological examination revealed dense lymphocytic infiltrate located around the epithelial structures of the adnexa and around the blood vessels. Immunohistochemistry showed predominantly T cells (CD34-positive, CD45 RO-positive cells). A diagnosis of palpable migratory arciform erythema was established and the patient was treated with oral tetracycline and topical corticosteroids. This treatment resulted in marked improvement within 7-10 days</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-AMB3OTYS"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-AMB3OTYS" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-AMB3OTYS/2f384bcf-7f48-4363-98ce-73cc62dc756f/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Združenje slovenskih dermatovenerologov</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-AMB3OTYS/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-AMB3OTYS" /></ore:Aggregation></rdf:RDF>